<!DOCTYPE html>
<html>
<head>
<meta charset = "utf-8">
<title>405 續發性高血壓</title>
<style type = "text/css">
table{width: 1100px; border-collapse: collapse; background-color: lightblue; font-family: sans-serif; margin:0px auto;}
table, td, th { border: 1px solid black; padding: 4px; }
th { text-align: left; color: white; background-color: darkblue; }
tr.oddrow { background-color: white; }
</style>
</head>
<body>
<table>
<caption>405-續發性高血壓</caption>
<thead><tr><th>ICD 405</th>
<th>Gene/Locus name</th>
<th>Location</th>
<th>Gene/Locus</th>
<th>Gene/Locus MIM number</th>
<th>Phenotype MIM number</th>
<th>Match in DOID</th>
<th>Match in Orphanet</th>
<th>Match distinct gene</th>
</tr>
</thead>
<tbody>
<tr class='oddrow'><td>405</td><td>Pseudohypoaldosteronism type IIA</td><td>1q31-q42</td><td>PHA2A, PHA2</td><td><a href="https://www.omim.org/entry/145260?search=145260" target="_blank">145260</a></td><td><a href="https://www.omim.org/entry/145260?search=145260" target="_blank">145260</a></td><td></td><td>YES</td><td></td></tr>
<tr><td>405</td><td>WNK lysine deficient protein kinase 4</td><td>17q21.2</td><td>WNK4, PRKWNK4, PHA2B</td><td><a href="https://www.omim.org/entry/601844?search=601844" target="_blank">601844</a></td><td><a href="https://www.omim.org/entry/614491?search=614491" target="_blank">614491</a></td><td></td><td>YES</td><td></td></tr>
<tr class='oddrow'><td>405</td><td>Kelch-like 3</td><td>5q31.2</td><td>KLHL3, PHA2D</td><td><a href="https://www.omim.org/entry/605775?search=605775" target="_blank">605775</a></td><td><a href="https://www.omim.org/entry/614495?search=614495" target="_blank">614495</a></td><td></td><td>YES</td><td></td></tr>
<tr><td>405</td><td>Cullin 3</td><td>2q36.2</td><td>CUL3, PHA2E</td><td><a href="https://www.omim.org/entry/603136?search=603136" target="_blank">603136</a></td><td><a href="https://www.omim.org/entry/614496?search=614496" target="_blank">614496</a></td><td></td><td>YES</td><td></td></tr>
<tr class='oddrow'><td>405</td><td>Renal failure, progressive, with hypertension</td><td>1q21</td><td>RFH1, AORF</td><td><a href="https://www.omim.org/entry/161900?search=161900" target="_blank">161900</a></td><td><a href="https://www.omim.org/entry/161900?search=161900" target="_blank">161900</a></td><td></td><td>YES</td><td></td></tr>
<tr><td>405</td><td>Nuclear receptor subfamily 3, group C, member 2 (mineralocorticoid receptor; aldosterone receptor)</td><td>4q31.23</td><td>NR3C2, MLR, MCR</td><td><a href="https://www.omim.org/entry/600983?search=600983" target="_blank">600983</a></td><td><a href="https://www.omim.org/entry/605115?search=605115" target="_blank">605115</a></td><td></td><td>YES</td><td></td></tr>
<tr class='oddrow'><td>405</td><td>WNK lysine deficient protein kinase 1</td><td>12p13.33</td><td>WNK1, PRKWNK1, KDP, PHA2C, HSAN2, HSN2</td><td><a href="https://www.omim.org/entry/605232?search=605232" target="_blank">605232</a></td><td><a href="https://www.omim.org/entry/614492?search=614492" target="_blank">614492</a></td><td></td><td>YES</td><td>WNK1:NOC2LP2(chr2:131443580)</td></tr>
<tr><td>405</td><td>Sodium channel, nonvoltage-gated 1, gamma</td><td>16p12.2</td><td>SCNN1G, PHA1, BESC3, LDLS2</td><td><a href="https://www.omim.org/entry/600761?search=600761" target="_blank">600761</a></td><td><a href="https://www.omim.org/entry/618114?search=618114" target="_blank">618114</a></td><td></td><td>YES</td><td></td></tr>
<tr class='oddrow'><td>405</td><td>Sodium channel, nonvoltage-gated 1, beta</td><td>16p12.2</td><td>SCNN1B, BESC1, LIDLS1</td><td><a href="https://www.omim.org/entry/600760?search=600760" target="_blank">600760</a></td><td><a href="https://www.omim.org/entry/177200?search=177200" target="_blank">177200</a></td><td></td><td>YES</td><td></td></tr>
</tbody></table>
</body>
</html>
